Renalytix (RENX): National distribution agreement
This situation live
RENX Renalytix
26 Mar 2026 · Contract discussions advancing · +77% until the next step
Management believes it is in the best interest of shareholders to conclude a national distribution agreement in calendar year 2026, to ensure access to the entire kidneyintelX.dkd eligible testing pat
1 Sep 2026 · Agreement signed; integration pending · +0% until the next step
kidneyintelX.dkd is expected to be available for physician ordering through Quest's connectivity services in the first quarter of 2027.
1 Sep 2026 · Funding raised; integration pending · +0% until the next step
kidneyintelX.dkd is expected to be available for physician ordering through the partner's ordering system in the first quarter of 2027.
3 Sep 2026 · Funding secured; interface build pending · +45% since
This Fundraise has significantly strengthened our balance sheet and allows us to pivot our operations to support national access and logistics with our new collaborator, Quest Diagnostics, for kidneyi
National distribution agreement
Funding secured; interface build pending
MAR31
Next: Quest ordering availability in 158 days
Every step · 4
- 26 Mar 2026 Contract discussions advancing – Management believes it is in the best interest of shareholders to conclude a national distribution agreement in calendar year 2026, to ensure access to the... ↗
- 1 Sep 2026 Agreement signed; integration pending – kidneyintelX.dkd is expected to be available for physician ordering through Quest's connectivity services in the first quarter of 2027. ↗
- 1 Sep 2026 Funding raised; integration pending – kidneyintelX.dkd is expected to be available for physician ordering through the partner's ordering system in the first quarter of 2027. ↗
- 3 Sep 2026 Funding secured; interface build pending – This Fundraise has significantly strengthened our balance sheet and allows us to pivot our operations to support national access and logistics with our new... ↗
What is happening
Renalytix: National distribution agreement – Funding secured; interface build pending. ['Funding secured; interface build pending']
- In short
- Renalytix signed a multi-year national distribution deal with Quest Diagnostics on 1 September 2026, with physician ordering expected in Q1 2027 and a target of 25,000 tests in 2027. The oversubscribed fundraise now funds the operational pivot to national access and logistics. Revenue still lags, since availability starts only in 2027.
- Announced
- 26 Mar 2026 · Contract discussions advancing
- Latest
- 3 Sep 2026 · Funding secured; interface build pending
What comes next
Quest ordering availability (31 Mar 2027).
Briefing Pro
New to Renalytix? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the RENX briefing →From the company's own announcements. Not investment advice.
Also at Renalytix 4 open
Insider conviction1 director buying – £70k in 1 buy
Transformational contract / build-outStrategic partnerships and EMR rollout – Funding secured; interface build pending
Dilutive fundraiseFundraise and debt conversion – Retail offer open; first tranche admission pending
Project milestonesTwo-year outcomes data and CE marking – Submitted for publication; CE review progressing
Renalytix – company page →